Healiva
Manufacturing · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Corso Elvezia 4, Lugano, Ticino, 6900, S...Phone Number
+41 919725005Website
www.healiva.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Healiva
Healiva is a patient-centric biotech company focused on developing innovative, personalized, and affordable therapies for chronic wound care. Their portfolio includes advanced solutions such as Epidex, AQUAtyrp Healiva 003, Healiva 002, and Healiva 004, aimed at improving patient outcomes and redefining wound healing. The company addresses the significant global challenge of chronic wounds, which affect millions and often require costly and inefficient treatments. Healiva's target clients include patients suffering from severe chronic wounds, particularly the elderly and diabetics.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Healiva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Healiva recently announced quarterly report
Healiva, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Healiva has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Healiva had a recent Job posting/layoffs
Check out if Healiva is spiking on competitors!
Product Launch: Get notified when Healiva launches new products
Congratulate Masked Content for being promoted to Masked Content at Healiva
Check if Healiva has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Healiva as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Healiva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Healiva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Healiva.
Healiva Tech Stack
A closer look at the technologies used by Healiva
Healiva News & Media
A New Hope for Epidermolysis Bullosa (“butterfly children”) Thanks to Novel CRISPR-Cas3 Platform
LUGANO, Switzerland & OSAKA, Japan--(BUSINESS WIRE)-- #CRISPRCas3--Healiva SA (Healiva) and C4U Corporation (C4U) are pleased to announce that they have entered into a strategic alliance agreement regarding the development of CRISPR-Cas3 derived therapeutic solutions for Epidermolysis Bullosa (EB), also known as “butterfly children”. Epidermolysis bullosa is a rare genetic skin disorder characterized by highly sensitive skin that blisters and erodes with minimal friction or trauma, such as rubbiHealiva® Announces Strategic Collaboration With Lausanne University Hospital to Manufacture EpiDex® for Severe Chronic Wound Treatment
LUGANO, Switzerland--(BUSINESS WIRE)-- #autologousepidermis--Healiva®, a patient-centric company delivering life-enhancing precision medicine for chronic wounds, announced today a strategic collaboration with Lausanne University Hospital (CHUV, ‘Centre Hospitalier Universitaire Vaudois’) for the manufacturing and approval of its autologous epidermal equivalent, Epidex®. Originating from the patient’s own hair follicles, EpiDex® enables non-invasive treatment of severe chronic venous leg ulcers (Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun
LUGANO, Switzerland--(BUSINESS WIRE)-- #Burdenofwounds--Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of critical manufacturing assets from B. Braun Medical AG Switzerland, an affiliate of German medical and pharmaceutical device company, B. Braun SE. The acquisition includes a qualified cell bank, which is essential for the GMP-compliant manufacturing of Healiva’s first cell therapy prHealiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew
LUGANO, Switzerland--(BUSINESS WIRE)-- #celltherapy--Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autol
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Healiva
Sign Up For FreeTo access detailed company insights
Healiva is a patient-centric biotech company focused on developing innovative, personalized, and affordable therapies for chronic wound care. Their portfolio includes advanced solutions such as Epidex, AQUAtyrp Healiva 003, Healiva 002, and Healiva 004, aimed at improving patient outcomes and redefining wound healing. The company addresses the sign... Read More
